Lewis R Roberts MD PhD
Biliary Tract Disease, Gastrointestinal Cancer, Hepatology & Liver Transplantation
Liver and Biliary Neoplasia at Mayo Clinic Rochester
Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Roberts is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified Gastroenterologist and Hepatologist specializing in the diagnosis and treatment of liver and biliary tract malignancies and liver mass lesions. I completed my Internal Medicine and Gastroenterology training at Mayo Clinic, where I serve as Associate Director of the Predoctoral Masters Degree Program in Clinical and Translational Sciences. My research interests are in hepatobiliary malignancies, spanning the spectrum from basic research into the signaling pathways regulating the growth, progression and metastases of liver and biliary cancers, translational studies of new biomarkers and diagnostic tests for early diagnosis, and epidemiological studies of the risk factors and determinants of development of liver and biliary cancers. I am also actively involved in educational and health policy initiatives to improve the prevention, access to care, and treatment of liver cancer patients in the United States, particularly including immigrant African and Asian communities, as well as in sub-Saharan Africa.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 1995 - 1998- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1992 - 1995
The University of IowaPhD, Physiology and Biophysics, 1986 - 1992
University of Ghana Medical SchoolClass of 1982
Certifications & Licensure
MN State Medical License 1994 - 2026
WI State Medical License 1995 - 2025
IA State Medical License 1995 - 2008
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (AGAF) American Gastroenterological Association, 2008
- Fellow (FASGE) American Society for Gastrointestinal Endoscopy
- Join now to see all
Clinical Trials
- Hepatitis B Research Network Adult Cohort Study Start of enrollment: 2010 Dec 01
- HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B Start of enrollment: 2011 Feb 01
- Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer Start of enrollment: 2012 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- CLO25-087: Low Serum Pseudocholinesterase Level Predicts HCC Mortality As Accurately As the ALBI or MESIAH Score.Angela Karina Sato Espinoza, Perapa Chotiprasidhi, Joseph J Larson, Lewis R Roberts, Kirk J Wangensteen
Journal of the National Comprehensive Cancer Network. 2025-03-28 - Social media use and the relationship with colorectal cancer screening among foreign-born populations in the United States.Joseph Atarere, Eugene Annor, Mariah Malak Bilalaga, Olachi Egbo, Greeshma N Gaddipati
Cancer Causes & Control. 2025-03-18 - 1 citationsGenetic, Epigenetic, and Microenvironmental Drivers of Cholangiocarcinoma.Vijay Putatunda, Apinya Jusakul, Lewis Roberts, Xin Wei Wang
The American Journal of Pathology. 2025-03-01
Journal Articles
- Clinical Features Associated with Survival Outcome in African-American Patients with Hepatocellular CarcinomaJennifer Leong, Lewis Roberts, Myron Schwartz, Mindie H Nguyen, Nature
Press Mentions
Blue Faery Gives Liver Cancer Research AwardApril 8th, 2022- The Blue Faery “Love Your Liver” Public Awareness CampaignFebruary 14th, 2022
- ‘Our Goal Is to Achieve a World Without Viral Hepatitis’October 1st, 2021
- Join now to see all
Grant Support
- Radiation and dendritic cell combination to improve immunotherapy response in intrahepatic cholangiocarcinomaMAYO CLINIC ROCHESTER2024–2029
- Radiation and dendritic cell combination to improve immunotherapy response in intrahepatic cholangiocarcinomaMAYO CLINIC ROCHESTER2024–2029
- Radiation and dendritic cell combination to improve immunotherapy response in intrahepatic cholangiocarcinomaMAYO CLINIC ROCHESTER2024–2029
- Mayo Clinic Hepatobiliary SPOREMAYO CLINIC ROCHESTER2018–2029
- Mayo Clinic Hepatobiliary SPOREMAYO CLINIC ROCHESTER2018–2029
- Mayo Clinic Hepatobiliary SPOREMAYO CLINIC ROCHESTER2018–2029
- International Consortium for the Genetics of Biliary Tract Cancers Cholangiocarcinoma Genome Wide Association StudyMAYO CLINIC ROCHESTER2023–2028
- Radiation and dendritic cells to hepatomas to improve immunotherapy responseMAYO CLINIC ROCHESTER2022–2027
- Radiation and dendritic cells to hepatomas to improve immunotherapy responseMAYO CLINIC ROCHESTER2022–2027
- Radiation and dendritic cells to hepatomas to improve immunotherapy responseMAYO CLINIC ROCHESTER2022–2027
- Africa Hepatopancreatobiliary Cancer ConsortiumMAYO CLINIC ROCHESTER2022–2025
- Regulation Of The Tumor Microenvironment In Hepatocellular CarcinomaNational Cancer Institute2012
- Dysregulation Of The Tumor Microenvironment In Hepatocellular CarcinomaNational Cancer Institute2009–2010
- Molecular Pathogenesis Of Hepatocellular CarcinomaNational Cancer Institute2009
- Molecular Pathogenesis Of Hepatocellular CarcinomaNational Cancer Institute2004–2008
- FRA16D Chromosomal Fragile Site In Liver CarcinogenesisNational Cancer Institute1999–2003
Professional Memberships
- Member
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
